Obesity and dyslipidemia in early life: Impact on cardiometabolic risk
Childhood obesity with its growing prevalence worldwide presents one of the most important health challenges nowadays. Multiple mechanisms are involved in the development of this condition, as well as in its associations with various cardiometabolic complications, such as insulin resistance, diabetes, metabolic dysfunction-associated steatotic liver disease and cardiovascular diseases. Recent findings suggest that childhood obesity and associated dyslipidemia at least partly originate from epigenetic modifications that take place in the earliest periods of life, namely prenatal and perinatal periods.
Source: Metabolism - Clinical and Experimental - Category: Biomedical Science Authors: Aleksandra Zeljkovic, Jelena Vekic, Aleksandra Stefanovic Tags: Review Source Type: research
More News: Biomedical Science | Cardiology | Cardiovascular | Child Development | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Insulin | Liver | Liver Disease | Obesity | Perinatology & Neonatology | Urology & Nephrology